LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_004655.4:c.1059+8C>T
AXIN2
· NP_004646.3:p.?
· NM_004655.4
GRCh37: chr17:63537565 G>A
·
GRCh38: chr17:65541447 G>A
Gene:
AXIN2
Transcript:
NM_004655.4
Final call
VUS
BP4 supporting
Variant details
Gene
AXIN2
Transcript
NM_004655.4
Protein
NP_004646.3:p.?
gnomAD AF
0.0002703136010618664 (v4.1)
ClinVar
Benign
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
VUS: BP4 (supporting) is met because SpliceAI maximum delta is 0.001, below the <=0.1 threshold.
Final determination:
Under generic ACMG/AMP 2015 fallback rules, one supporting benign criterion alone does not meet the thresholds for Benign or Likely Benign, so the final classification is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Not met | Not met: noncanonical c.1059+8 intronic variant has no established protein consequence and SpliceAI max delta 0.001, so generic PVS1 is unsupported. |
pvs1_generic_framework
spliceai
PMID:25741868
|
| PS1 | N/A | Not applicable: c.1059+8C>T is intronic with predicted protein consequence p.?, so no amino-acid change exists for PS1 comparison. |
spliceai
|
| PS2 | Not assessed | Not assessed: no parental testing or confirmed de novo occurrence is documented for NM_004655.4:c.1059+8C>T. |
|
| PS3 | Not assessed | Not assessed: no variant-specific RNA, protein, cellular, or other validated functional assay result was reported for AXIN2 c.1059+8C>T. |
|
| PS4 | Not assessed | Not assessed: no exact-variant case-control enrichment, affected-case count, odds ratio, or other prevalence metric is available. |
PMID:25394175
|
| PM1 | N/A | Not applicable: the intronic variant has predicted protein consequence p.?, so it cannot be mapped to a missense functional domain or residue hotspot. |
spliceai
|
| PM2 | Not met | Not met: the default gnomAD v4.1 overall allele frequency is 0.000270314, above the generic PM2 threshold of 0.0001. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| PM3 | Not assessed | Not assessed: no affected-proband observation or documented pathogenic variant in trans, phase, or recessive inheritance context is available. |
|
| PM4 | N/A | Not applicable: c.1059+8C>T is intronic with protein consequence p.?, not an established in-frame coding length change. |
pvs1_variant_assessment
|
| PM5 | N/A | Not applicable: c.1059+8C>T is intronic with protein consequence p.?, so PM5's same-residue missense comparison cannot be performed. |
|
| PM6 | Not assessed | Not assessed: no presumed de novo report, proband phenotype, or parental-testing context is documented for this variant. |
|
| PP1 | Not assessed | Not assessed: zero informative familial meioses or affected-relative segregation observations are documented for this variant. |
|
| PP2 | N/A | Not applicable: the variant is intronic with predicted protein consequence p.?, whereas PP2 is restricted to missense variants. |
|
| PP3 | Not met | Not met: SpliceAI maximum delta 0.001 is below the >=0.2 supporting PP3 threshold. |
spliceai
|
| PP4 | Not assessed | Not assessed: no patient phenotype is documented to evaluate specificity for an AXIN2-related disorder. |
|
| PP5 | Not met | Not met: exact-variant ClinVar record 136475 has 0 expert-panel submissions and no Pathogenic or Likely pathogenic expert-panel classification. |
clinvar
|
| BA1 | Not met | Not met: the highest default all-comers population allele frequency is 0.00770843, below the generic BA1 threshold of 0.05. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS1 | Not met | Not met: the highest default all-comers population allele frequency is 0.00770843, below the generic BS1 threshold of 0.01. |
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD reports 3 homozygotes, but unaffected status and AXIN2 penetrance are not established for BS2. |
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no controlled variant-specific assay demonstrated normal or benign AXIN2 function for c.1059+8C>T. |
|
| BS4 | Not assessed | Not assessed: no genotype-confirmed affected and unaffected relatives are available to demonstrate non-segregation. |
|
| BP1 | N/A | Not applicable: c.1059+8C>T is intronic with predicted protein consequence p.?, not a missense variant required for BP1. |
|
| BP2 | Not assessed | Not assessed: no documented in-trans or in-cis pathogenic-variant co-occurrence, phase result, or applicable inheritance context is available. |
|
| BP3 | N/A | Not applicable: the variant is a noncanonical intronic SNV, not an in-frame deletion or insertion in a repetitive protein region. |
pvs1_variant_assessment
|
| BP4 | Met | Met, supporting: SpliceAI maximum delta 0.001 is below the <=0.1 BP4 threshold. |
spliceai
|
| BP5 | Not assessed | Not assessed: no documented in-cis pathogenic variant or co-occurrence evidence is available for this exact variant. |
|
| BP6 | Not met | Not met: exact-variant ClinVar record 136475 has 0 expert-panel submissions, so single-submitter Benign/Likely benign labels do not qualify for BP6. |
clinvar
|
| BP7 | N/A | Not applicable: the variant is an intronic splice-region change, not a synonymous variant. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.